Early membrane initiated transcriptional effects of estrogens in breast cancer cells: First pharmacological evidence for a novel membrane estrogen receptor element (ERx)

Steroids

Volumn 77, Issue 10, 2012, Pages 959-967

  Kampa, Marilena ^a   Notas, George ^a   Pelekanou, Vassiliki ^a   Troullinaki, Maria ^a   Andrianaki, Maria ^a   Azariadis, Kalliopi ^a   Kampouri, Errika ^a   Lavrentaki, Katerina ^a   Castanas, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Breast cancer; Estrogen receptors; Transcriptional effects

Indexed keywords

CANCER GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; HORMONE RECEPTOR BLOCKING AGENT; TRANSCRIPTOME;

APOPTOSIS; BREAST CANCER; CANCER CELL CULTURE; CELL FUNCTION; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MEMBRANE PERMEABILITY; PHENOTYPE; TRANSCRIPTION REGULATION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DNA-BINDING PROTEINS; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ESTROGEN; SERUM ALBUMIN, BOVINE; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84863985276     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.02.011     Document Type: Conference Paper

References (54)

1. Z. Madak-Erdogan, M. Lupien, F. Stossi, M. Brown, and B.S. Katzenellenbogen Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs Mol Cell Biol 31 2011 226 236
2. C. Thomas, and J.A. Gustafsson The different roles of ER subtypes in cancer biology and therapy Nat Rev Cancer 11 2011 597 608
3. S.R. Hammes, and E.R. Levin Extranuclear steroid receptors: nature and actions Endocr Rev 28 2007 726 741 (Pubitemid 350294293)
4. G.G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, and J.A. Gustafsson Cloning of a novel receptor expressed in rat prostate and ovary Proc Natl Acad Sci USA 93 1996 5925 5930 (Pubitemid 26190778)
5. P. Walter, S. Green, G. Greene, A. Krust, J.M. Bornert, and J.M. Jeltsch Cloning of the human estrogen receptor cDNA Proc Natl Acad Sci USA 82 1985 7889 7893 (Pubitemid 16179869)
6. I. Poola, S. Koduri, S. Chatra, and R. Clarke Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach J Steroid Biochem Mol Biol 72 2000 249 258 (Pubitemid 30261529)
7. S.A. Fuqua, R. Schiff, I. Parra, W.E. Friedrichs, J.L. Su, and D.D. McKee Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer Cancer Res 59 1999 5425 5428 (Pubitemid 29526449)
8. B. Peng, B. Lu, E. Leygue, and L.C. Murphy Putative functional characteristics of human estrogen receptor-beta isoforms J Mol Endocrinol 30 2003 13 29 (Pubitemid 36305253)
9. E.J. Filardo, J.A. Quinn, A.R. Frackelton Jr., and K.I. Bland Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis Mol Endocrinol 16 2002 70 84 (Pubitemid 34044499)
10. G. Langer, B. Bader, L. Meoli, J. Isensee, M. Delbeck, and P.R. Noppinger A critical review of fundamental controversies in the field of GPR30 research Steroids 75 2010 603 610
11. C.G. Bologa, C.M. Revankar, S.M. Young, B.S. Edwards, J.B. Arterburn, and A.S. Kiselyov Virtual and biomolecular screening converge on a selective agonist for GPR30 Nat Chem Biol 2 2006 207 212
12. M.K. Dennis, R. Burai, C. Ramesh, W.K. Petrie, S.N. Alcon, and T.K. Nayak In vivo effects of a GPR30 antagonist Nat Chem Biol 5 2009 421 427
13. Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, et al. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol; 2011.
14. F. Acconcia, P. Ascenzi, A. Bocedi, E. Spisni, V. Tomasi, and A. Trentalance Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol Mol Biol Cell 16 2005 231 237 (Pubitemid 40028339)
15. G. Reid, M.R. Hubner, R. Metivier, H. Brand, S. Denger, and D. Manu Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling Mol Cell 11 2003 695 707 (Pubitemid 36385123)
16. D. Gallo, I. Haddad, G. Laurent, J. Vinh, F. Jacquemotte, and Y. Jacquot Regulatory function of the P295-T311 motif of the estrogen receptor alpha - does proteasomal degradation of the receptor induce emergence of peptides implicated in estrogenic responses? Nucl Recept Signal 6 2008 e007
17. M. Kampa, V. Pelekanou, D. Gallo, G. Notas, M. Troullinaki, and I. Pediaditakis ERalpha17p, an ERalpha P(295)-T(311) fragment, modifies the migration of breast cancer cells, through actin cytoskeleton rearrangements J Cell Biochem 112 2011 3786 3796
18. A. Essaghir, F. Toffalini, L. Knoops, A. Kallin, J. van Helden, and J.B. Demoulin Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data Nucleic Acids Res 38 2010 e120
19. V.I. Alexaki, I. Charalampopoulos, M. Kampa, H. Vassalou, P. Theodoropoulos, and E.N. Stathopoulos Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation FASEB J 18 2004 1594 1596 (Pubitemid 39561644)
20. V. Pelekanou, G. Notas, E. Sanidas, A. Tsapis, E. Castanas, and M. Kampa Testosterone membrane-initiated action in breast cancer cells: interaction with the androgen signaling pathway and EPOR Mol Oncol 4 2010 135 149
21. Z. Madak-Erdogan, K.J. Kieser, S.H. Kim, B. Komm, J.A. Katzenellenbogen, and B.S. Katzenellenbogen Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors Mol Endocrinol 22 2008 2116 2127
22. S. Borges, E. Moudilou, C. Vouyovitch, J. Chiesa, P. Lobie, and H. Mertani Involvement of a JAK/STAT pathway inhibitor: cytokine inducible SH2 containing protein in breast cancer Adv Exp Med Biol 617 2008 321 329
23. D.S. Mern, K. Hoppe-Seyler, F. Hoppe-Seyler, J. Hasskarl, and B. Burwinkel Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells Breast Cancer Res Treat 124 2010 623 633
24. K. Blyth, E.R. Cameron, and J.C. Neil The RUNX genes: gain or loss of function in cancer Nat Rev Cancer 5 2005 376 387 (Pubitemid 40637829)
25. G.L. Barnes, K.E. Hebert, M. Kamal, A. Javed, T.A. Einhorn, and J.B. Lian Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease Cancer Res 64 2004 4506 4513 (Pubitemid 38856922)
26. C.P. Alvarez-Baron, P. Jonsson, C. Thomas, S.E. Dryer, and C. Williams The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells Mol Endocrinol 25 2011 1326 1336
27. N.S. Wickramasinghe, T.T. Manavalan, S.M. Dougherty, K.A. Riggs, Y. Li, and C.M. Klinge Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells Nucleic Acids Res 37 2009 2584 2595
28. A. Bruzzone, C.P. Pinero, L.F. Castillo, M.G. Sarappa, P. Rojas, and C. Lanari Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice Br J Pharmacol 155 2008 494 504
29. I.A. Luthy, A. Bruzzone, C.P. Pinero, L.F. Castillo, I.J. Chiesa, and S.M. Vazquez Adrenoceptors: non conventional target for breast cancer? Curr Med Chem 16 2009 1850 1862
30. D.G. Powe, M.J. Voss, H.O. Habashy, K.S. Zanker, A.R. Green, and I.O. Ellis Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study Breast Cancer Res Treat 130 2011 457 463
31. M. Kampa, A.P. Nifli, I. Charalampopoulos, V.I. Alexaki, P.A. Theodoropoulos, and E.N. Stathopoulos Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis Exp Cell Res 307 2005 41 51 (Pubitemid 40732732)
32. V.I. Alexaki, I. Charalampopoulos, M. Kampa, A.P. Nifli, A. Hatzoglou, and A. Gravanis Activation of membrane estrogen receptors induce pro-survival kinases J Steroid Biochem Mol Biol 98 2006 97 110 (Pubitemid 43153782)
33. O. Treeck, G. Pfeiler, F. Horn, B. Federhofer, H. Houlihan, and A. Vollmer Novel estrogen receptor beta transcript variants identified in human breast cancer cells affect cell growth and apoptosis of COS-1 cells Mol Cell Endocrinol 264 2007 50 60 (Pubitemid 46097299)
34. M. Vilar, I. Charalampopoulos, R.S. Kenchappa, A. Simi, E. Karaca, and A. Reversi Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers Neuron 62 2009 72 83
35. C. Otto, B. Rohde-Schulz, G. Schwarz, I. Fuchs, M. Klewer, and D. Brittain G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol Endocrinology 149 2008 4846 4856
36. C. Sanden, S. Broselid, L. Cornmark, K. Andersson, J. Daszkiewicz-Nilsson, and U.E. Martensson G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments Mol Pharmacol 79 2011 400 410
37. L. Kang, X. Zhang, Y. Xie, Y. Tu, D. Wang, and Z. Liu Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling Mol Endocrinol 24 2010 709 721
38. L. Li, M.P. Haynes, and J.R. Bender Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells Proc Natl Acad Sci USA 100 2003 4807 4812 (Pubitemid 36457810)
39. F. Acconcia, and M. Marino The effects of 17beta-estradiol in cancer are mediated by estrogen receptor signaling at the plasma membrane Front Physiol 2 2011 30
40. A.A. Shemetov, A.S. Seit-Nebi, and N.B. Gusev Structure, properties, and functions of the human small heat-shock protein HSP22 (HspB8, H11, E2IG1): a critical review J Neurosci Res 86 2008 264 269 (Pubitemid 351196732)
41. P.E. Stevis, D.C. Deecher, L. Suhadolnik, L.M. Mallis, and D.E. Frail Differential effects of estradiol and estradiol-BSA conjugates Endocrinology 140 1999 5455 5458
42. R.X. Song, Y. Chen, Z. Zhang, Y. Bao, W. Yue, and J.P. Wang Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells J Steroid Biochem Mol Biol 118 2010 219 230
43. D. Dubik, and R.P. Shiu Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells J Biol Chem 263 1988 12705 12708 (Pubitemid 19000455)
44. K.E. Luker, and G.D. Luker Functions of CXCL12 and CXCR4 in breast cancer Cancer Lett 238 2006 30 41 (Pubitemid 44183757)
45. J. Frasor, F. Stossi, J.M. Danes, B. Komm, C.R. Lyttle, and B.S. Katzenellenbogen Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells Cancer Res 64 2004 1522 1533 (Pubitemid 38235626)
46. M.V. Barone, R. Pepperkok, F.A. Peverali, and L. Philipson Id proteins control growth induction in mammalian cells Proc Natl Acad Sci USA 91 1994 4985 4988 (Pubitemid 24177775)
47. S. Fong, Y. Itahana, T. Sumida, J. Singh, J.P. Coppe, and Y. Liu Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis Proc Natl Acad Sci USA 100 2003 13543 13548 (Pubitemid 37444778)
48. D.Y. Wang, B. McKague, S.N. Liss, and E.A. Edwards Gene expression profiles for detecting and distinguishing potential endocrine-disrupting compounds in environmental samples Environ Sci Technol 38 2004 6396 6406 (Pubitemid 39578655)
49. Yarden RI, Wilson MA, Chrysogelos SA, Estrogen suppression of EGFR expression in breast cancer cells: a possible mechanism to modulate growth. J Cell Biochem Suppl. 2001;(Suppl 36):232-46.
50. T. Wang, D. Xia, N. Li, C. Wang, T. Chen, and T. Wan Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis J Biol Chem 280 2005 4374 4382 (Pubitemid 41741357)
51. J. Tesarik, L. Garrigosa, and C. Mendoza Estradiol modulates breast cancer cell apoptosis: a novel nongenomic steroid action relevant to carcinogenesis Steroids 64 1999 22 27 (Pubitemid 29168584)
52. M.S. Giretti, X.D. Fu, G. De Rosa, I. Sarotto, C. Baldacci, and S. Garibaldi Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion PLoS ONE 3 2008 e2238
53. A.M. Sanchez, M.I. Flamini, C. Baldacci, L. Goglia, A.R. Genazzani, and T. Simoncini Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP Mol Endocrinol 24 2010 2114 2125
54. V. Pelekanou, M. Kampa, M. Kafousi, K. Dambaki, K. Darivianaki, and T. Vrekoussis Erythropoietin and its receptor in breast cancer: correlation with steroid receptors and outcome Cancer Epidemiol Biomarkers Prev 16 2007 2016 2023 (Pubitemid 47621175)